Filing Details
- Accession Number:
- 0001179110-19-004245
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-25 20:10:53
- Reporting Period:
- 2019-03-21
- Accepted Time:
- 2019-03-25 20:10:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697362 | Burkes Michael Brophy | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-21 | 1,118 | $0.00 | 11,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-22 | 273 | $20.20 | 11,075 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2019-03-21 | 1,118 | $0.00 | 1,118 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2019-03-22 | 17,236 | $0.00 | 17,236 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2019-03-22 | 50,000 | $0.00 | 50,000 | $19.68 |
| Common Stock | Restricted Stock Units | Acquisiton | 2019-03-22 | 100,000 | $0.00 | 100,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,938 | No | 4 | M | Direct | ||
| 17,236 | No | 4 | A | Direct | ||
| 50,000 | 2029-03-21 | No | 4 | A | Direct | |
| 100,000 | 2029-03-21 | No | 4 | A | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018.
- Each RSU represents a contingent right to receive one share of the common stock of the issuer.
- The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
- The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vest on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter
- The option shares vest over four years. 25% of the option shares vest and become exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
- Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the achievement of the Performance Vesting Conditions.
- The RSU vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions").
Billionaire Hedge Funds
